Tapewire

NYSE · USD

AGX

ARGAN INC

Export transactions ↓
Tapewire entity
3828
SEC CIK
0000100591
Parsed reports
327

Last 12 months

Inside the activity.

0 purchase rows · 37 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202503
Jan 202608
Feb 202600
Mar 202601
Apr 2026013
May 202600
Jun 2026011
Jul 202601
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
April 16, 2026 Filed Apr 20, 2026 21:00 UTC
Watson David HibbertDirector · PRESIDENT AND CEO
Exercise / conversionCommon Stock 736 $0.00 $0.00
Disclosure

SEC source: 0001482442-26-000006 · form4-04202026_050405.xml · nonDerivative · entry 2

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,737

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · shares: Pursuant to the three-year vesting schedule of the TRSUs awarded to the Reporting Person on April 16, 2025, 1,333 shares of Common Stock became issuable to the Reporting Person on April 16, 2026 and is adjusted for dividends.

Read SEC document
April 16, 2026 Filed Apr 20, 2026 21:00 UTC
Watson David HibbertDirector · PRESIDENT AND CEO
Exercise / conversionCommon Stock 1,869 $0.00 $0.00
Disclosure

SEC source: 0001482442-26-000006 · form4-04202026_050405.xml · nonDerivative · entry 1

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,001

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Units ("TRSUs") awarded to the Reporting Person on April 16, 2024, 3,333 shares of Common Stock became issuable to the Reporting Person on April 16, 2026 and is adjusted for dividends.

Read SEC document
April 16, 2026 Filed Apr 20, 2026 21:00 UTC
Baugher Joshua ScottChief Financial Officer
Exercise / conversionTime-Based Restricted Stock Units · Derivative 667 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0002066213-26-000006 · form4-04202026_050403.xml · derivative · entry 6

Baugher Joshua Scott · CIK 0002066213 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,043

Underlying: Common Stock · 667 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Pursuant to the three-year vesting schedule of the TRSUs awarded to the Reporting Person on April 16, 2025, 667 shares of common stock became issuable to the Reporting Person on April 16, 2026 and is adjusted for dividends.

F2 · derivative.expiration_date: Pursuant to the three-year vesting schedule of the TRSUs awarded to the Reporting Person on April 16, 2025, 667 shares of common stock became issuable to the Reporting Person on April 16, 2026 and is adjusted for dividends.

Read SEC document
April 16, 2026 Filed Apr 20, 2026 21:00 UTC
Baugher Joshua ScottChief Financial Officer
Exercise / conversionTime-Based Restricted Stock Units · Derivative 1,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0002066213-26-000006 · form4-04202026_050403.xml · derivative · entry 5

Baugher Joshua Scott · CIK 0002066213 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,710

Underlying: Common Stock · 1,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Units ("TRSUs") awarded to the Reporting Person on April 16, 2024, 1,000 shares of common stock became issuable to the Reporting Person on April 16, 2026 and is adjusted for dividends.

F1 · derivative.expiration_date: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Units ("TRSUs") awarded to the Reporting Person on April 16, 2024, 1,000 shares of common stock became issuable to the Reporting Person on April 16, 2026 and is adjusted for dividends.

Read SEC document
April 16, 2026 Filed Apr 20, 2026 21:00 UTC
Baugher Joshua ScottChief Financial Officer
SaleCommon Stock 600 $605.60 $363,360.00
Disclosure

SEC source: 0002066213-26-000006 · form4-04202026_050403.xml · nonDerivative · entry 3

Baugher Joshua Scott · CIK 0002066213 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,479

F3 · shares: On April 16, 2026, the Reporting Person sold 600 shares of the Issuer's common stock on the open market at an average price of $605.60 per share.

Read SEC document
April 16, 2026 Filed Apr 20, 2026 21:00 UTC
Baugher Joshua ScottChief Financial Officer
Exercise / conversionCommon Stock 335 $0.00 $0.00
Disclosure

SEC source: 0002066213-26-000006 · form4-04202026_050403.xml · nonDerivative · entry 2

Baugher Joshua Scott · CIK 0002066213 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,079

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · shares: Pursuant to the three-year vesting schedule of the TRSUs awarded to the Reporting Person on April 16, 2025, 667 shares of common stock became issuable to the Reporting Person on April 16, 2026 and is adjusted for dividends.

Read SEC document
April 16, 2026 Filed Apr 20, 2026 21:00 UTC
Baugher Joshua ScottChief Financial Officer
Exercise / conversionCommon Stock 509 $0.00 $0.00
Disclosure

SEC source: 0002066213-26-000006 · form4-04202026_050403.xml · nonDerivative · entry 1

Baugher Joshua Scott · CIK 0002066213 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,744

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Units ("TRSUs") awarded to the Reporting Person on April 16, 2024, 1,000 shares of common stock became issuable to the Reporting Person on April 16, 2026 and is adjusted for dividends.

Read SEC document
April 16, 2026 Filed Apr 20, 2026 21:00 UTC Exercise / conversionTime-Based Restricted Stock Units · Derivative 695 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001771393-26-000009 · form4-04202026_050401.xml · derivative · entry 2

Larroque Alexander Lisa · CIK 0001771393 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 530

Underlying: Common Stock · 695 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Pursuant to the one-year vesting schedule of the Time-Based Restricted Stock Units ("TRSUs") awarded to the Reporting Person on April 16, 2025, 695 shares of common stock became issuable to the Reporting Person on April 16, 2026 and is adjusted for dividends.

F1 · derivative.expiration_date: Pursuant to the one-year vesting schedule of the Time-Based Restricted Stock Units ("TRSUs") awarded to the Reporting Person on April 16, 2025, 695 shares of common stock became issuable to the Reporting Person on April 16, 2026 and is adjusted for dividends.

Read SEC document
April 16, 2026 Filed Apr 20, 2026 21:00 UTC Exercise / conversionCommon Stock 700 $0.00 $0.00
Disclosure

SEC source: 0001771393-26-000009 · form4-04202026_050401.xml · nonDerivative · entry 1

Larroque Alexander Lisa · CIK 0001771393 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 700

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Pursuant to the one-year vesting schedule of the Time-Based Restricted Stock Units ("TRSUs") awarded to the Reporting Person on April 16, 2025, 695 shares of common stock became issuable to the Reporting Person on April 16, 2026 and is adjusted for dividends.

Read SEC document
April 13, 2026 Filed Apr 15, 2026 11:38 UTC SaleCommon Stock 8,444 $598.49 $5,053,649.56
Disclosure

SEC source: 0001361943-26-000008 · form4-04152026_110453.xml · nonDerivative · entry 1

Leimkuhler William F. · CIK 0001361943 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,495

F1 · shares: On April 13, 2026, the Reporting Person sold 8,444 shares of the Issuer's common stock on the open market at an average price of $598.49 per share.

Read SEC document
April 08, 2026 Filed Apr 10, 2026 20:30 UTC
Collins Charles Edwin IVCHIEF EXECUTIVE OFFICER, GEMMA
GrantEarnings Per Share Performance Based Restricted Stock Units · Derivative 2,618 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001791800-26-000002 · form4-04102026_040407.xml · derivative · entry 4

Collins Charles Edwin IV · CIK 0001791800 · CHIEF EXECUTIVE OFFICER, GEMMA

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,118

Underlying: Common Stock · 2,618 shares

Expires not disclosed

F4 · derivative.exercise_date: On April 8, 2026, the Reporting Person was granted Earnings Per Share Performance-Based Restricted Stock Units ("EPSRSUs") in the target number of 2,618 shares, the vesting of which is subject to the sum of Earnings Per Share ("EPS") for fiscal years ending January 31, 2027, 2028 and 2029 compared to target compounded growth EPS amounts based on the sum of EPS for the fiscal years ended January 31, 2024, 2025 and 2026. The pay-out ratio of the target number of 2,618 shares, ranging from 0% to 200%, will depend on the degree of achievement of the EPS ranking at the end of the three-year performance period.

F4 · derivative.expiration_date: On April 8, 2026, the Reporting Person was granted Earnings Per Share Performance-Based Restricted Stock Units ("EPSRSUs") in the target number of 2,618 shares, the vesting of which is subject to the sum of Earnings Per Share ("EPS") for fiscal years ending January 31, 2027, 2028 and 2029 compared to target compounded growth EPS amounts based on the sum of EPS for the fiscal years ended January 31, 2024, 2025 and 2026. The pay-out ratio of the target number of 2,618 shares, ranging from 0% to 200%, will depend on the degree of achievement of the EPS ranking at the end of the three-year performance period.

Read SEC document
April 08, 2026 Filed Apr 10, 2026 20:30 UTC
Collins Charles Edwin IVCHIEF EXECUTIVE OFFICER, GEMMA
GrantPerformance Based Restricted Stock Units · Derivative 170 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001791800-26-000002 · form4-04102026_040407.xml · derivative · entry 3

Collins Charles Edwin IV · CIK 0001791800 · CHIEF EXECUTIVE OFFICER, GEMMA

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,670

Underlying: Common Stock · 170 shares

Expires not disclosed

F3 · derivative.exercise_date: On April 8, 2026, the Reporting Person was granted Performance-Based Restricted Stock Units ("PRSUs") in the target number of 170 shares, the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies to be disclosed in the Issuer's 2026 Proxy Statement. Each PRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the target number of 170 shares, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period.

F3 · derivative.expiration_date: On April 8, 2026, the Reporting Person was granted Performance-Based Restricted Stock Units ("PRSUs") in the target number of 170 shares, the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies to be disclosed in the Issuer's 2026 Proxy Statement. Each PRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the target number of 170 shares, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period.

Read SEC document
April 08, 2026 Filed Apr 10, 2026 20:30 UTC
Collins Charles Edwin IVCHIEF EXECUTIVE OFFICER, GEMMA
GrantTime Based Restricted Stock Units · Derivative 231 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001791800-26-000002 · form4-04102026_040407.xml · derivative · entry 2

Collins Charles Edwin IV · CIK 0001791800 · CHIEF EXECUTIVE OFFICER, GEMMA

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,564

Underlying: Common Stock · 231 shares

Expires not disclosed

F2 · derivative.exercise_date: On April 8, 2026 the Reporting Person was granted Time-Based Restricted Stock Units ("TRSUs") covering 231 shares of common stock. The TRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 4/8/2027.

F2 · derivative.expiration_date: On April 8, 2026 the Reporting Person was granted Time-Based Restricted Stock Units ("TRSUs") covering 231 shares of common stock. The TRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 4/8/2027.

Read SEC document
April 08, 2026 Filed Apr 10, 2026 20:30 UTC
Collins Charles Edwin IVCHIEF EXECUTIVE OFFICER, GEMMA
GrantOption to Purchase Common Stock · Derivative 332 $0.00 Strike: $588.28 $0.00
Disclosure

SEC source: 0001791800-26-000002 · form4-04102026_040407.xml · derivative · entry 1

Collins Charles Edwin IV · CIK 0001791800 · CHIEF EXECUTIVE OFFICER, GEMMA

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,067

Underlying: Common Stock · 332 shares

Expires 2036-04-08

F1 · shares: On April 8, 2026, the Reporting Person received 10-year options to purchase 332 shares of the Issuer's common stock with an exercise price of $588.28 per share. The options will vest ratably over three years on each anniversary of the grant date starting on 4/8/2027.

Read SEC document
April 08, 2026 Filed Apr 10, 2026 20:30 UTC
Watson David HibbertDirector · PRESIDENT AND CEO
GrantEarnings Per Share Performance-Based Restricted Stock Units · Derivative 3,339 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001482442-26-000002 · form4-04102026_040405.xml · derivative · entry 4

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,839

Underlying: Common Stock · 3,339 shares

Expires not disclosed

F4 · derivative.exercise_date: On April 8, 2026, the Reporting Person was granted Earnings Per Share Performance-Based Restricted Stock Units ("EPSRSUs") in the target number of 3,339 shares, the vesting of which is subject to the sum of Earnings Per Share ("EPS") for fiscal years ending January 31, 2027, 2028 and 2029 compared to target compounded growth EPS amounts based on the sum of EPS for the fiscal years ended January 31, 2024, 2025 and 2026. The pay-out ratio of the target number of 3,339 shares, ranging from 0% to 200%, will depend on the degree of achievement of the EPS ranking at the end of the three-year performance period.

F4 · derivative.expiration_date: On April 8, 2026, the Reporting Person was granted Earnings Per Share Performance-Based Restricted Stock Units ("EPSRSUs") in the target number of 3,339 shares, the vesting of which is subject to the sum of Earnings Per Share ("EPS") for fiscal years ending January 31, 2027, 2028 and 2029 compared to target compounded growth EPS amounts based on the sum of EPS for the fiscal years ended January 31, 2024, 2025 and 2026. The pay-out ratio of the target number of 3,339 shares, ranging from 0% to 200%, will depend on the degree of achievement of the EPS ranking at the end of the three-year performance period.

Read SEC document
April 08, 2026 Filed Apr 10, 2026 20:30 UTC
Watson David HibbertDirector · PRESIDENT AND CEO
GrantPerformance-Based Restricted Stock Units · Derivative 284 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001482442-26-000002 · form4-04102026_040405.xml · derivative · entry 3

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,284

Underlying: Common Stock · 284 shares

Expires not disclosed

F3 · derivative.exercise_date: On April 8, 2026, the Reporting Person was granted Performance-Based Restricted Stock Units ("PRSUs") in the target number of 284 shares, the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies to be disclosed in the Issuer's 2026 Proxy Statement. Each PRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the target number of 284 shares, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period.

F3 · derivative.expiration_date: On April 8, 2026, the Reporting Person was granted Performance-Based Restricted Stock Units ("PRSUs") in the target number of 284 shares, the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies to be disclosed in the Issuer's 2026 Proxy Statement. Each PRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the target number of 284 shares, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period.

Read SEC document
April 08, 2026 Filed Apr 10, 2026 20:30 UTC
Watson David HibbertDirector · PRESIDENT AND CEO
GrantTime-Based Restricted Stock Units · Derivative 251 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001482442-26-000002 · form4-04102026_040405.xml · derivative · entry 2

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,918

Underlying: Common Stock · 251 shares

Expires not disclosed

F2 · derivative.exercise_date: On April 8, 2026, the Reporting Person was granted Time-Based Restricted Stock Units ("TRSUs") covering 251 shares of common stock. The TRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 4/8/2027.

F2 · derivative.expiration_date: On April 8, 2026, the Reporting Person was granted Time-Based Restricted Stock Units ("TRSUs") covering 251 shares of common stock. The TRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 4/8/2027.

Read SEC document
April 08, 2026 Filed Apr 10, 2026 20:30 UTC
Watson David HibbertDirector · PRESIDENT AND CEO
GrantOption to Purchase Common Stock · Derivative 415 $0.00 Strike: $588.28 $0.00
Disclosure

SEC source: 0001482442-26-000002 · form4-04102026_040405.xml · derivative · entry 1

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,081

Underlying: Common Stock · 415 shares

Expires 2036-04-08

F1 · shares: On April 8, 2026, the Reporting Person received 10-year options to purchase 415 shares of the Issuer's common stock with an exercise price of $588.28 per share. The options will vest ratably over three years on each anniversary of the grant date starting on 4/8/2027.

Read SEC document
April 08, 2026 Filed Apr 10, 2026 20:30 UTC
Griffin William F JrDirector · GEMMA, NON-EXECUTIVE CHAIRMAN
GrantEarnings Per Share Performance-Based Restricted Stock Units · Derivative 3,339 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001384123-26-000002 · form4-04102026_040403.xml · derivative · entry 1

Griffin William F Jr · CIK 0001384123 · Director · GEMMA, NON-EXECUTIVE CHAIRMAN

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,339

Underlying: Common Stock · 3,339 shares

Expires not disclosed

F1 · derivative.exercise_date: On April 8, 2026, the Reporting Person was granted Earnings Per Share Performance-Based Restricted Stock Units ("EPSRSUs") in the target number of 3,339 shares, the vesting of which is subject to the sum of Earnings Per Share ("EPS") for fiscal years ending January 31, 2027, 2028 and 2029 compared to target compounded growth EPS amounts based on the sum of EPS for the fiscal years ended January 31, 2024, 2025 and 2026. The pay-out ratio of the target number of 3,339 shares, ranging from 0% to 200%, will depend on the degree of achievement of the EPS ranking at the end of the three-year performance period.

F1 · derivative.expiration_date: On April 8, 2026, the Reporting Person was granted Earnings Per Share Performance-Based Restricted Stock Units ("EPSRSUs") in the target number of 3,339 shares, the vesting of which is subject to the sum of Earnings Per Share ("EPS") for fiscal years ending January 31, 2027, 2028 and 2029 compared to target compounded growth EPS amounts based on the sum of EPS for the fiscal years ended January 31, 2024, 2025 and 2026. The pay-out ratio of the target number of 3,339 shares, ranging from 0% to 200%, will depend on the degree of achievement of the EPS ranking at the end of the three-year performance period.

Read SEC document
April 08, 2026 Filed Apr 10, 2026 20:30 UTC
Baugher Joshua ScottChief Financial Officer
GrantEarnings Per Share Performance-Based Restricted Stock Units · Derivative 1,670 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0002066213-26-000002 · form4-04102026_040401.xml · derivative · entry 4

Baugher Joshua Scott · CIK 0002066213 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,420

Underlying: Common Stock · 1,670 shares

Expires not disclosed

F4 · derivative.exercise_date: On April 8, 2025, the Reporting Person was granted Earnings Per Share Performance-Based Restricted Stock Units ("EPSRSUs") in the target number of 1,670 shares, the vesting of which is subject to the sum of Earnings Per Share ("EPS") for fiscal years ending January 31, 2027, 2028 and 2029 compared to target compounded growth EPS amounts based on the sum of EPS for the fiscal years ended January 31, 2024, 2025 and 2026. The pay-out ratio of the target number of 1,670 shares, ranging from 0% to 200%, will depend on the degree of achievement of the EPS ranking at the end of the three-year performance period.

F4 · derivative.expiration_date: On April 8, 2025, the Reporting Person was granted Earnings Per Share Performance-Based Restricted Stock Units ("EPSRSUs") in the target number of 1,670 shares, the vesting of which is subject to the sum of Earnings Per Share ("EPS") for fiscal years ending January 31, 2027, 2028 and 2029 compared to target compounded growth EPS amounts based on the sum of EPS for the fiscal years ended January 31, 2024, 2025 and 2026. The pay-out ratio of the target number of 1,670 shares, ranging from 0% to 200%, will depend on the degree of achievement of the EPS ranking at the end of the three-year performance period.

Read SEC document
April 08, 2026 Filed Apr 10, 2026 20:30 UTC
Baugher Joshua ScottChief Financial Officer
GrantPerformance-Based Restricted Stock Units · Derivative 142 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0002066213-26-000002 · form4-04102026_040401.xml · derivative · entry 3

Baugher Joshua Scott · CIK 0002066213 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,642

Underlying: Common Stock · 142 shares

Expires not disclosed

F3 · derivative.exercise_date: On April 8, 2026, the Reporting Person was granted Performance-Based Restricted Stock Units ("PRSUs") in the target number of 142 shares, the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies to be disclosed in the Issuer's 2026 Proxy Statement. Each PRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the target number of 142 shares, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period.

F3 · derivative.expiration_date: On April 8, 2026, the Reporting Person was granted Performance-Based Restricted Stock Units ("PRSUs") in the target number of 142 shares, the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies to be disclosed in the Issuer's 2026 Proxy Statement. Each PRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the target number of 142 shares, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period.

Read SEC document
April 08, 2026 Filed Apr 10, 2026 20:30 UTC
Baugher Joshua ScottChief Financial Officer
GrantTime-Based Restricted Stock Units · Derivative 126 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0002066213-26-000002 · form4-04102026_040401.xml · derivative · entry 2

Baugher Joshua Scott · CIK 0002066213 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,710

Underlying: Common Stock · 126 shares

Expires not disclosed

F2 · derivative.exercise_date: On April 8, 2026, the Reporting Person was granted TRSUs covering 126 shares of common stock. The TRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 4/8/2027.

F2 · derivative.expiration_date: On April 8, 2026, the Reporting Person was granted TRSUs covering 126 shares of common stock. The TRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 4/8/2027.

Read SEC document
April 08, 2026 Filed Apr 10, 2026 20:30 UTC
Baugher Joshua ScottChief Financial Officer
GrantOption to Purchase Common Stock · Derivative 208 $0.00 Strike: $588.28 $0.00
Disclosure

SEC source: 0002066213-26-000002 · form4-04102026_040401.xml · derivative · entry 1

Baugher Joshua Scott · CIK 0002066213 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,708

Underlying: Common Stock · 208 shares

Expires 2036-04-08

F1 · shares: On April 8, 2026, the Reporting Person was granted a 10-year option to purchase 208 shares of the Issuer's common stock at an exercise price of $588.28 per share. The options will vest ratably over three years on each anniversary of the grant date starting on 4/8/2027.

Read SEC document
April 02, 2026 Filed Apr 2, 2026 21:00 UTC GiftCommon Stock 1,000 $0.00 $0.00
Disclosure

SEC source: 0001627519-26-000004 · form4-04022026_050404.xml · nonDerivative · entry 4

Getsinger Peter W · CIK 0001627519 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,847

F4 · shares: On April 2, 2026, the Reporting Person made a bona fide gift of 1,000 shares of the Issuer's common stock.

Read SEC document
April 02, 2026 Filed Apr 2, 2026 21:00 UTC SaleCommon Stock 2,581 $552.73 $1,426,596.13
Disclosure

SEC source: 0001627519-26-000004 · form4-04022026_050404.xml · nonDerivative · entry 3

Getsinger Peter W · CIK 0001627519 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,847

F3 · shares: On April 2, 2026, the Reporting Person sold 2,581 shares of the Issuer's common stock on the open market at an average price of $552.73 per share.

Read SEC document
April 01, 2026 Filed Apr 2, 2026 21:00 UTC Exercise / conversionOption to Purchase Common Stock · Derivative 1,000 $43.70 Strike: $43.70 $43,700.00
Disclosure

SEC source: 0001627519-26-000004 · form4-04022026_050404.xml · derivative · entry 8

Getsinger Peter W · CIK 0001627519 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,000

Underlying: Common Stock · 1,000 shares

Expires 2034-12-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · shares: On April 1, 2026, the Reporting Person exercised a portion of his stock option awarded on December 14, 2023 to purchase 1,000 shares of the Issuer's common stock at a price of $43.70 per share, using the net settle method.

Read SEC document
April 01, 2026 Filed Apr 2, 2026 21:00 UTC Exercise / conversionOption to Purchase Common Stock · Derivative 5,000 $37.13 Strike: $37.13 $185,650.00
Disclosure

SEC source: 0001627519-26-000004 · form4-04022026_050404.xml · derivative · entry 7

Getsinger Peter W · CIK 0001627519 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,000

Underlying: Common Stock · 5,000 shares

Expires 2031-12-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On April 1, 2026, the Reporting Person exercised his stock option awarded on December 14, 2021 to purchase 5,000 shares of the Issuer's common stock at a price of $37.13 per share, using the net settle method.

Read SEC document
April 01, 2026 Filed Apr 2, 2026 21:00 UTC Exercise / conversionCommon Stock 920 $43.70 $40,204.00
Disclosure

SEC source: 0001627519-26-000004 · form4-04022026_050404.xml · nonDerivative · entry 2

Getsinger Peter W · CIK 0001627519 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,428

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · shares: On April 1, 2026, the Reporting Person exercised a portion of his stock option awarded on December 14, 2023 to purchase 1,000 shares of the Issuer's common stock at a price of $43.70 per share, using the net settle method.

Read SEC document
April 01, 2026 Filed Apr 2, 2026 21:00 UTC Exercise / conversionCommon Stock 4,661 $37.13 $173,062.93
Disclosure

SEC source: 0001627519-26-000004 · form4-04022026_050404.xml · nonDerivative · entry 1

Getsinger Peter W · CIK 0001627519 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,508

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On April 1, 2026, the Reporting Person exercised his stock option awarded on December 14, 2021 to purchase 5,000 shares of the Issuer's common stock at a price of $37.13 per share, using the net settle method.

Read SEC document
March 31, 2026 Filed Apr 2, 2026 21:00 UTC SaleCommon Stock 4,556 $539.85 $2,459,556.60
Disclosure

SEC source: 0001709914-26-000012 · form4-04022026_050401.xml · nonDerivative · entry 1

Jeffrey John Ronald Jr. · CIK 0001709914 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,636

F1 · shares: On March 31, 2026, the Reporting Person sold 4,556 shares of the Issuer's common stock on the open market at an average price of $539.85 per share.

Read SEC document
January 27, 2026 Filed Jan 29, 2026 22:00 UTC SaleCommon Stock 5,000 $360.78 $1,803,900.00
Disclosure

SEC source: 0001709914-26-000008 · form4-01292026_050101.xml · nonDerivative · entry 1

Jeffrey John Ronald Jr. · CIK 0001709914 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,192

F1 · shares: On January 27, 2026, the Reporting Person sold 5,000 shares of the Issuer's common stock on the open market at an average price of $360.78 per share.

Read SEC document
January 21, 2026 Filed Jan 23, 2026 22:00 UTC SaleCommon Stock 19,000 $386.70 $7,347,300.00
Disclosure

SEC source: 0001463638-26-000004 · form4-01232026_050101.xml · nonDerivative · entry 1

Flanders Cynthia · CIK 0001463638 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,207

F1 · shares: On January 21, 2026, the Reporting Person sold 19,000 shares of the Issuer's common stock on the open market at an average price of $386.70 per share.

Read SEC document
January 20, 2026 Filed Jan 21, 2026 22:00 UTC SaleCommon Stock 2,700 $380.60 $1,027,620.00
Disclosure

SEC source: 0001709914-26-000004 · form4-01212026_050104.xml · nonDerivative · entry 2

Jeffrey John Ronald Jr. · CIK 0001709914 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,192

F2 · shares: On January 20, 2026, the Reporting Person sold 2,700 shares of the Issuer's common stock on the open market at an average price of $380.60 per share.

Read SEC document
January 16, 2026 Filed Jan 21, 2026 22:00 UTC Exercise / conversionOption to Purchase Common Stock · Derivative 10,000 $45.75 Strike: $45.75 $457,500.00
Disclosure

SEC source: 0001709914-26-000004 · form4-01212026_050104.xml · derivative · entry 4

Jeffrey John Ronald Jr. · CIK 0001709914 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,500

Underlying: Common Stock · 10,000 shares

Expires 2030-12-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On January 16, 2026, the Reporting Person exercised his stock option awarded on December 14, 2020 to purchase 10,000 shares of the Issuer's common stock at a price of $45.75 per share, using the net settle method.

Read SEC document
January 16, 2026 Filed Jan 21, 2026 22:00 UTC Exercise / conversionCommon Stock 8,636 $45.75 $395,097.00
Disclosure

SEC source: 0001709914-26-000004 · form4-01212026_050104.xml · nonDerivative · entry 1

Jeffrey John Ronald Jr. · CIK 0001709914 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,892

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On January 16, 2026, the Reporting Person exercised his stock option awarded on December 14, 2020 to purchase 10,000 shares of the Issuer's common stock at a price of $45.75 per share, using the net settle method.

Read SEC document
January 16, 2026 Filed Jan 21, 2026 22:00 UTC SaleCommon Stock 11,044 $379.15 $4,187,332.60
Disclosure

SEC source: 0001361943-26-000006 · form4-01212026_050101.xml · nonDerivative · entry 1

Leimkuhler William F. · CIK 0001361943 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,939

F1 · shares: On January 16, 2026, the Reporting Person sold 11,044 shares of the Issuer's common stock at an average price of of $379.15 per share.

Read SEC document
January 13, 2026 Filed Jan 14, 2026 22:00 UTC Exercise / conversionOption to Purchase Common Stock · Derivative 5,000 $35.72 Strike: $35.72 $178,600.00
Disclosure

SEC source: 0001463638-26-000002 · form4-01142026_050103.xml · derivative · entry 8

Flanders Cynthia · CIK 0001463638 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,500

Underlying: Common Stock · 5,000 shares

Expires 2032-12-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · shares: On January 13, 2026, the Reporting Person exercised her stock option awarded on December 16, 2022 to purchase 5,000 shares of the Issuer's common stock at a price of $35.72 per share, using the net settle method.

Read SEC document
January 13, 2026 Filed Jan 14, 2026 22:00 UTC Exercise / conversionOption to Purchase Common Stock · Derivative 5,000 $37.13 Strike: $37.13 $185,650.00
Disclosure

SEC source: 0001463638-26-000002 · form4-01142026_050103.xml · derivative · entry 7

Flanders Cynthia · CIK 0001463638 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,500

Underlying: Common Stock · 5,000 shares

Expires 2031-12-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · shares: On January 13, 2026, the Reporting Person exercised her stock option awarded on December 14, 2021 to purchase 5,000 shares of the Issuer's common stock at a price of $37.13 per share, using the net settle method.

Read SEC document
January 13, 2026 Filed Jan 14, 2026 22:00 UTC Exercise / conversionOption to Purchase Common Stock · Derivative 10,000 $45.75 Strike: $45.75 $457,500.00
Disclosure

SEC source: 0001463638-26-000002 · form4-01142026_050103.xml · derivative · entry 6

Flanders Cynthia · CIK 0001463638 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,500

Underlying: Common Stock · 10,000 shares

Expires 2030-12-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · shares: On January 13, 2026, the Reporting Person exercised her stock option awarded on December 14, 2020 to purchase 10,000 shares of the Issuer's common stock at a price of $45.75 per share, using the net settle method.

Read SEC document
January 13, 2026 Filed Jan 14, 2026 22:00 UTC Exercise / conversionOption to Purchase Common Stock · Derivative 10,000 $40.15 Strike: $40.15 $401,500.00
Disclosure

SEC source: 0001463638-26-000002 · form4-01142026_050103.xml · derivative · entry 5

Flanders Cynthia · CIK 0001463638 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,500

Underlying: Common Stock · 10,000 shares

Expires 2029-12-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On January 13, 2026, the Reporting Person exercised her stock option awarded on December 23, 2019 to purchase 10,000 shares of the Issuer's common stock at a price of $40.15 per share, using the net settle method.

Read SEC document
January 13, 2026 Filed Jan 14, 2026 22:00 UTC Exercise / conversionCommon Stock 4,427 $35.72 $158,132.44
Disclosure

SEC source: 0001463638-26-000002 · form4-01142026_050103.xml · nonDerivative · entry 4

Flanders Cynthia · CIK 0001463638 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,207

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · shares: On January 13, 2026, the Reporting Person exercised her stock option awarded on December 16, 2022 to purchase 5,000 shares of the Issuer's common stock at a price of $35.72 per share, using the net settle method.

Read SEC document
January 13, 2026 Filed Jan 14, 2026 22:00 UTC Exercise / conversionCommon Stock 4,405 $37.13 $163,557.65
Disclosure

SEC source: 0001463638-26-000002 · form4-01142026_050103.xml · nonDerivative · entry 3

Flanders Cynthia · CIK 0001463638 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,780

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · shares: On January 13, 2026, the Reporting Person exercised her stock option awarded on December 14, 2021 to purchase 5,000 shares of the Issuer's common stock at a price of $37.13 per share, using the net settle method.

Read SEC document
January 13, 2026 Filed Jan 14, 2026 22:00 UTC Exercise / conversionCommon Stock 8,534 $45.75 $390,430.50
Disclosure

SEC source: 0001463638-26-000002 · form4-01142026_050103.xml · nonDerivative · entry 2

Flanders Cynthia · CIK 0001463638 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,375

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · shares: On January 13, 2026, the Reporting Person exercised her stock option awarded on December 14, 2020 to purchase 10,000 shares of the Issuer's common stock at a price of $45.75 per share, using the net settle method.

Read SEC document
January 13, 2026 Filed Jan 14, 2026 22:00 UTC Exercise / conversionCommon Stock 8,713 $40.15 $349,826.95
Disclosure

SEC source: 0001463638-26-000002 · form4-01142026_050103.xml · nonDerivative · entry 1

Flanders Cynthia · CIK 0001463638 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,841

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On January 13, 2026, the Reporting Person exercised her stock option awarded on December 23, 2019 to purchase 10,000 shares of the Issuer's common stock at a price of $40.15 per share, using the net settle method.

Read SEC document
January 13, 2026 Filed Jan 14, 2026 22:00 UTC SaleCommon Stock 4,212 $320.53 $1,350,072.36
Disclosure

SEC source: 0001361943-26-000004 · form4-01142026_050101.xml · nonDerivative · entry 2

Leimkuhler William F. · CIK 0001361943 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,983

F2 · shares: On January 13, 2026, the Reporting Person sold 4,212 shares of the Issuer's common stock on the open market at an average price of $320.53 per share.

Read SEC document
January 12, 2026 Filed Jan 14, 2026 22:00 UTC SaleCommon Stock 2,164 $318.28 $688,757.92
Disclosure

SEC source: 0001361943-26-000004 · form4-01142026_050101.xml · nonDerivative · entry 1

Leimkuhler William F. · CIK 0001361943 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,195

F1 · shares: On January 12, 2026, the Reporting Person sold 2,164 shares of the Issuer's common stock on the open market at an average price of $318.28 per share.

Read SEC document
January 08, 2026 Filed Jan 9, 2026 23:41 UTC SaleCommon Stock 6,595 $313.71 $2,068,917.45
Disclosure

SEC source: 0001627519-26-000002 · form4-01092026_110127.xml · nonDerivative · entry 3

Getsinger Peter W · CIK 0001627519 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,847

F3 · shares: On January 8, 2026, the Reporting Person sold 6,595 shares of the Issuer's common stock on the open market at an average price of $313.71 per share.

Read SEC document
January 07, 2026 Filed Jan 9, 2026 22:00 UTC Exercise / conversionOption to Purchase Common Stock · Derivative 5,000 $35.72 Strike: $35.72 $178,600.00
Disclosure

SEC source: 0001361943-26-000002 · form4-01092026_050101.xml · derivative · entry 8

Leimkuhler William F. · CIK 0001361943 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,500

Underlying: Common Stock · 5,000 shares

Expires 2032-12-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · shares: On January 7, 2026, the Reporting Person exercised his stock option awarded on December 16, 2022 to purchase 5,000 shares of the Issuer's common stock at a price of $35.72 per share, using the net settle method.

Read SEC document
January 07, 2026 Filed Jan 9, 2026 22:00 UTC Exercise / conversionOption to Purchase Common Stock · Derivative 5,000 $37.13 Strike: $37.13 $185,650.00
Disclosure

SEC source: 0001361943-26-000002 · form4-01092026_050101.xml · derivative · entry 7

Leimkuhler William F. · CIK 0001361943 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,500

Underlying: Common Stock · 5,000 shares

Expires 2031-12-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · shares: On January 7, 2026, the Reporting Person exercised his stock option awarded on December 14, 2021 to purchase 5,000 shares of the Issuer's common stock at a price of $37.13 per share, using the net settle method.

Read SEC document
January 07, 2026 Filed Jan 9, 2026 22:00 UTC Exercise / conversionOption to Purchase Common Stock · Derivative 10,000 $45.75 Strike: $45.75 $457,500.00
Disclosure

SEC source: 0001361943-26-000002 · form4-01092026_050101.xml · derivative · entry 6

Leimkuhler William F. · CIK 0001361943 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,500

Underlying: Common Stock · 10,000 shares

Expires 2030-12-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · shares: On January 7, 2026, the Reporting Person exercised his stock option awarded on December 14, 2020 to purchase 10,000 shares of the Issuer's common stock at a price of $45.75 per share, using the net settle method.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.